These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 30351372)

  • 41. Twenty years of surveillance of Invasive Meningococcal Diseases in Puglia, Italy.
    Stefanelli P; Fazio C; Neri A; Di Taranto A; Labonia M; De Robertis AL; Loconsole D; Martinelli D; Chironna M
    Ann Ist Super Sanita; 2015; 51(4):366-70. PubMed ID: 26783226
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Clinical Picture and Severity of Invasive Meningococcal Disease Serogroup W Compared With Other Serogroups in the Netherlands, 2015-2018.
    Loenenbach AD; van der Ende A; de Melker HE; Sanders EAM; Knol MJ
    Clin Infect Dis; 2020 May; 70(10):2036-2044. PubMed ID: 31556938
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Risk of invasive meningococcal disease in children and adults with HIV in England: a population-based cohort study.
    Simmons RD; Kirwan P; Beebeejaun K; Riordan A; Borrow R; Ramsay ME; Delpech V; Lattimore S; Ladhani S
    BMC Med; 2015 Dec; 13():297. PubMed ID: 26654248
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence and serogroup changes of Neisseria meningitidis in South Korea, 2010-2016.
    Lee H; Seo Y; Kim KH; Lee K; Choe KW
    Sci Rep; 2018 Mar; 8(1):5292. PubMed ID: 29593277
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epidemiology of invasive meningococcal disease in Austria 2010.
    Steindl G; Liu YL; Schmid D; Orendi U; Kormann-Klement A; Heuberger S
    Wien Klin Wochenschr; 2011 Oct; 123 Suppl 1():10-4. PubMed ID: 21935643
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epidemiology of invasive meningococcal disease in the Netherlands, 1960-2012: an analysis of national surveillance data.
    Bijlsma MW; Bekker V; Brouwer MC; Spanjaard L; van de Beek D; van der Ende A
    Lancet Infect Dis; 2014 Sep; 14(9):805-12. PubMed ID: 25104306
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Laboratory surveillance for invasive meningococcal disease in Chile, 2006-2012].
    Araya P; Díaz J; Seoane M; Fernández J; Terrazas S; Canals A; Vaquero A; Barra G; Hormazábal JC; Pidal P; Valenzuela MT
    Rev Chilena Infectol; 2014 Aug; 31(4):377-84. PubMed ID: 25327189
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recent changes in the epidemiology of Neisseria meningitidis serogroup W across the world, current vaccination policy choices and possible future strategies.
    Booy R; Gentile A; Nissen M; Whelan J; Abitbol V
    Hum Vaccin Immunother; 2019; 15(2):470-480. PubMed ID: 30296197
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Australian Meningococcal Surveillance Programme Annual Report, 2021.
    Lahra MM; George CR; Hogan TR
    Commun Dis Intell (2018); 2022 Jul; 46():. PubMed ID: 35860868
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rise in invasive serogroup W meningococcal disease in Australia 2013-2015.
    Martin NV; Ong KS; Howden BP; Lahra MM; Lambert SB; Beard FH; Dowse GK; Saul N;
    Commun Dis Intell Q Rep; 2016 Dec; 40(4):E454-E459. PubMed ID: 28043219
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of Meningococcal B Vaccine on Invasive Meningococcal Disease in Adolescents.
    McMillan M; Wang B; Koehler AP; Sullivan TR; Marshall HS
    Clin Infect Dis; 2021 Jul; 73(1):e233-e237. PubMed ID: 33587122
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular characterization of a collection of Neisseria meningitidis isolates from Croatia, June 2009 to January 2014.
    Bukovski S; Vacca P; Anselmo A; Knezovic I; Fazio C; Neri A; Ciammaruconi A; Fortunato A; Palozzi AM; Fillo S; Lista F; Stefanelli P
    J Med Microbiol; 2016 Sep; 65(9):1013-1019. PubMed ID: 27452726
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Invasive Meningococcal Disease in Africa's Meningitis Belt: More Than Just Meningitis?
    Reese HE; Ronveaux O; Mwenda JM; Bita A; Cohen AL; Novak RT; Fox LM; Soeters HM
    J Infect Dis; 2019 Oct; 220(220 Suppl 4):S263-S265. PubMed ID: 31671435
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Penicillin- and Ciprofloxacin-Resistant Invasive Neisseria meningitidis Isolates from Japan.
    Saito R; Nakajima J; Prah I; Morita M; Mahazu S; Ota Y; Kobayashi A; Tohda S; Kamiya H; Takahashi H; Ohnishi M
    Microbiol Spectr; 2022 Jun; 10(3):e0062722. PubMed ID: 35467371
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epidemiology of invasive meningococcal disease in Greece, 2006-2016.
    Flountzi A; Georgakopoulou T; Balasegaram S; Kesanopoulos K; Xirogianni A; Papandreou A; Tzanakaki G;
    Eur J Clin Microbiol Infect Dis; 2019 Dec; 38(12):2197-2203. PubMed ID: 31418100
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of routine immunization using meningococcal C conjugate vaccine on invasive meningococcal disease in British Columbia.
    Siu T; Tang W; Dawar M; Patrick DM
    Can J Public Health; 2008; 99(5):380-2. PubMed ID: 19009920
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Surveillance of invasive meningococcal disease in the south of Brazil: considerations of immunization programme.
    Silveira MM; Crespo da Silva PA; Conrad NL; Oliveira TL; Hartwig DD; Trotter C
    J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33544069
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Temporal associations between national outbreaks of meningococcal serogroup W and C disease in the Netherlands and England: an observational cohort study.
    Knol MJ; Hahné SJM; Lucidarme J; Campbell H; de Melker HE; Gray SJ; Borrow R; Ladhani SN; Ramsay ME; van der Ende A
    Lancet Public Health; 2017 Oct; 2(10):e473-e482. PubMed ID: 29253430
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Annual report of the Australian Meningococcal Surveillance Programme, 2009.
    Australian Meningococcal Surveillance Programme
    Commun Dis Intell Q Rep; 2010 Sep; 34(3):291-302. PubMed ID: 21090184
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Invasive meningococcal disease in older adults in North America and Europe: is this the time for action? A review of the literature.
    Guedes S; Bertrand-Gerentes I; Evans K; Coste F; Oster P
    BMC Public Health; 2022 Feb; 22(1):380. PubMed ID: 35197024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.